Institutional HoldersBeta
Who holds a company, from every 13F filed for the quarter, one row per filer exactly as filed, against the latest share count the company reported.
Share classes (cover page of the 20-F filed 2026-04-30, as of 2025-12-31)
| Class | Listed | Shares outstanding | Held by 13F filers | % of class | Holders | CUSIP |
|---|---|---|---|---|---|---|
| Common stock | YDES · NASDAQ | 70,789,261 | 284,369 | 0.4% | 13 | G98301107 |
Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.
Top holders (13 of 13 · G98301107)
change vs 2026-03-31| # | Filer | Shares | % of class | Value | Change |
|---|---|---|---|---|---|
| 1 | Garrett Wealth Advisory Group, LLC | 84,630 | 0.12% | $190K | NEW |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 62,714 | 0.09% | $141K | +2,478 (+4.1%) |
| 3 | Cypress Capital Management LLC (WY) | 33,690 | 0.05% | $76K | +3,000 (+9.8%) |
| 4 | Cerity Partners LLC | 32,406 | 0.05% | $73K | — |
| 5 | CITADEL ADVISORS LLC | 30,106 | 0.04% | $68K | +10,656 (+54.8%) |
| 6 | JANE STREET GROUP, LLC | 21,423 | 0.03% | $48K | NEW |
| 7 | UBS Group AG | 12,384 | 0.02% | $28K | +756 (+6.5%) |
| 8 | WOLVERINE ASSET MANAGEMENT LLC | 4,886 | 0.01% | $11K | — |
| 9 | SkyView Investment Advisors, LLC | 1,777 | 0.00% | $4K | NEW |
| 10 | MORGAN STANLEY | 160 | 0.00% | $360 | -63 (-28.3%) |
| 11 | ROYAL BANK OF CANADA | 117 | 0.00% | $0 | NEW |
| 12 | WELLS FARGO & COMPANY/MN | 75 | 0.00% | $169 | NEW |
| 13 | FMR LLC | 1 | 0.00% | $2 | — |
Large holders from 13D/13G (latest per reporting person, last 2 years)
Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.
| Reporting person | Form | Filed | Event | Shares | % of class |
|---|---|---|---|---|---|
| Ethan Shen | SCHEDULE 13G/A | 2026-02-17 | 2026-02-17 | 54,345,011 | 77.06% |
| YD Biopharma Holding Limited | SCHEDULE 13G/A | 2026-02-17 | 2026-02-17 | 43,120,858 | 61.15% |
| EG Biomed Limited | SCHEDULE 13G | 2025-12-16 | 2025-09-30 | 11,224,153 | 15.9% |
Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.